Serum waits for India’s green signal for COVID-19 vaccine use


Serum waits for India’s green signal for COVID-19 vaccine use: Serum Institute of India, which is also manufacturing the Oxford-AstraZeneca coronavirus vaccine in India, said that it expected the government to approve the shot for emergency use in a few days.

 

The company has already made 40 million to 50 million doses of the vaccine and will be able to ramp up capacity to around 100 million a month by March when a new facility comes online.

 

"We have 40-50 million doses of Covishield stockpiled. Once we get regulatory approvals in a few days, it'll be down to the government to decide how much they can take and how fast," Serum Chief Executive Adar Poonawalla said.

 

"All data on Oxford-AstraZeneca COVID19 vaccine submitted in India and UK. There are no concerns, regulators are closely reviewing documents and data," informed Serum CEO. Poonawalla also told the reporters that India is a part of 'COVAX' and hence, the company will keep giving 50% of everything we make to India and to COVAX at the same time. However, he added that since India was a large population, the company will "probably end up giving the majority of those 50 million doses to India first."

Comments

Popular posts from this blog

Prizm Payment Services changes its name to Hitachi Payment Services

Japan's Sharp to buy Toshiba PC business for $36 mln